| Pharmaceutical active ingredients: |
| NimesulideOrphenadrine Citrate |
| Available forms, composition and doses of Mio-Virobron: |
| N / A |
| Mio-Virobron medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| M01AX17 - NimesulideM02AA26 - NimesulideM03BC51 - Orphenadrine, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Temis Lostalo Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Lostamucil | Psyllium | Temis Lostalo Laboratorios |
| Lostapres | Ramipril | Temis Lostalo Laboratorios |
| Lostapride | Mosapride Citrate | Temis Lostalo Laboratorios |
| Lostaprolol | Bisoprolol Fumarate | Temis Lostalo Laboratorios |
| Mamograf | Charcoal Activated | Temis Lostalo Laboratorios |
| Mio-Virobron NF | Diclofenac Sodium; Pridinol Mesylate | Temis Lostalo Laboratorios |
| Molival | Bromazepam | Temis Lostalo Laboratorios |
| Neo Pelvicillin | Chlorpheniramine Maleate; Gramicidin; Hydrocortisone; Neomycin Sulfate; Neomycin Undecenoate; Nitrofurazone | Temis Lostalo Laboratorios |
| Neomas | Neomycin Sulfate | Temis Lostalo Laboratorios |
| Neomas L | Loperamide Hydrochloride; Neomycin Sulfate | Temis Lostalo Laboratorios |